STWRY yields 0.12% · PFE yields 6.13%● Live data
📍 PFE pulled ahead of the other in Year 8
Combined, STWRY + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of STWRY + PFE for your $10,000?
Software Aktiengesellschaft provides software development, licensing, maintenance, and IT services in Germany, the United States, and internationally. It operates through three segments: Digital Business Platform, Adabas & Natural, and Professional Services. The company offers Internet of Things (IoT) and analytics solutions comprising Cumulocity IoT for integrating digital equipment and sensors through an IoT device management and application enablement platform, as well as provides streaming analytics for big data analytics in real time and solutions for predictive analytics, artificial intelligence (AI), and machine learning; and TrendMiner, an intuitive Web-based analytics platform for visualization of industrial processes and process data. It also provides webMethods that integrate systems, applications, and processes through application programming interfaces or direct connections and orchestrate them in the form of microservices; ARIS for modeling, documenting, and optimizing business processes; Alfabet, which enables enterprise architecture mapping and optimal decision making for IT investments; Adabas & Natural for transaction processing; and CONNX for data integration, virtualization, and replication. In addition, the company offers professional services, which include implementation, development, and upgrade/migration services. Software Aktiengesellschaft was founded in 1969 and is headquartered in Darmstadt, Germany.
Full STWRY Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.